Posted on 7/8/19
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that on July 1, 2019, . . .
Posted on 7/8/19
LabShares Newton Selects L Stem Therapeutics as Winner of Second Launch@LabShares Competition Valued at $50K
NEWTON, Mass.--(BUSINESS WIRE)--LabShares Newton, a shared office and laboratory incubator for emerging biotechnology and life science companies, announced at Thursday’s MALSI Day that L Stem Therapeutics . . .
Posted on 7/8/19
Blue Cross Blue Shield of Massachusetts Sponsors Free Rides on Bluebikes for 4th of July
Riders can use the code “BlueCross4” in the Bluebikes app to access free Bluebikes rides all day courtesy of Blue Cross, the title sponsor of Metro . . .
Posted on 7/3/19
T2 Biosystems Reports Granting of Inducement Awards
LEXINGTON, Mass., July 03, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical . . .
Posted on 7/3/19
Bristol-Myers: Otezla Divestiture Highlights Compelling Opportunity
SummaryBristol-Myers reported that it will divest Celgene’s psoriasis product Otezla to ease FTC’s anti-trust concerns.The divestiture will result in BMY pushing the BMY/CELG deal close to . . .
Posted on 7/3/19
Karuna Therapeutics Closes Initial Public Offering
BOSTON--(BUSINESS WIRE)--Karuna Therapeutics, Inc. (Nasdaq: KRTX), a clinical-stage biopharmaceutical company primarily focused on developing novel therapies to address disabling neuropsychiatric conditions, today announced the closing of . . .
Posted on 7/3/19
LogicBio Secures Up To $20 Million Debt Facility
CAMBRIDGE, Mass., July 02, 2019 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (Nasdaq: LOGC), a genome editing company focused on developing medicines to durably treat rare diseases, . . .
Posted on 7/2/19
Cybrexa Therapeutics Receives SBIR Grant to Support Development of Lead Candidate CBX-11 in Combination with Chemotherapy Agents
NEW HAVEN, Conn., July 02, 2019 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics, a biotechnology company developing a new class of cancer therapeutics through its alphalex™ tumor targeting . . .
Posted on 7/2/19
Vertex Pharmaceuticals: A Stock That Continues To Impress In 2019
SummaryKalydeco, Orkambi, and Symdeko continue to report robust demand trends in CF population.FDA approval for Vertex's triplet regimen can dramatically expand its addressable CF market.The company . . .
Posted on 7/2/19
CVS Health: Trapped Between Growth Expectations And Uncertainty
SummaryJudge Leon will decide about the CVS-Aetna merger in July, and there is a lot of uncertainty what will happen if the merger is blocked retroactive.At . . .
Posted on 7/2/19
Morphic Closes Initial Public Offering
WALTHAM, Mass.--(BUSINESS WIRE)--Morphic Holding, Inc., a biopharmaceutical company discovering and developing oral small-molecule integrin therapeutics, today announced the closing of its initial public offering of 6,900,000 . . .
Posted on 7/1/19
Virtua Acquires Lourdes Health System
Effective July 1, 2019, Virtua has assumed ownership of Lourdes Health System, a transaction that reshapes health care in South Jersey.
Posted on 7/1/19
Miraca and Seventh Sense Biosystems Announce Investment
Seventh Sense Biosystems, Inc. (7SBio), makers of TAP, the world's first push-button blood collection device, and Miraca Holdings Inc. or Miraca ($MRCHF),
Posted on 7/1/19
Bristol-Myers Squibb Completes Divestment of UPSA
Bristol-Myers Squibb Company (NYSE:BMY) announced today that effective July 1, 2019 it has completed its previously announced divestment of its consumer health business, UPSA
Posted on 7/1/19
3 Top Biotech Stocks to Buy Right Now
Over the prior decade, you'd be hard-pressed to find a better performing subsector than biotechnology. A number of biotech stocks, after all, have produced life-changing returns . . .
Posted on 7/1/19
ConvenientMD Partners with Health Insurance Companies
ConvenientMD—New England's leading provider of urgent care services—is proud to announce the addition of office-based infusion therapy centers within ConvenientMD locations. This initiative provides enhanced patient . . .
Posted on 6/30/19
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., June 28, 2019 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on June . . .
Posted on 6/30/19
Karyopharm Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
NEWTON, Mass., June 28, 2019 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a clinical-stage pharmaceutical company, today announced that the Compensation Committee of Karyopharm’s Board . . .
Posted on 6/30/19
T2 Biosystems Named One of the Fastest-Growing Companies in Massachusetts
LEXINGTON, Mass., June 28, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in . . .
Posted on 6/30/19
Peak Physical Therapy & Sports Performance Adds Cynthia Wisted, PT, DPT, at Hanover Clinic
Peak Physical Therapy & Sports Performance, a South Shore practice specializing in unique programs that
Posted on 6/28/19
Acer Therapeutics: Despite Receiving A Devastating CRL, The Story Isn't Over
SummaryAcer received a Complete Response Letter (CRL) from the FDA earlier this week denying approval of EDSIVO and requiring a new clinical trial be conducted.Apart from . . .
Posted on 6/28/19
Allena Pharmaceuticals Announces $10.0M Registered Direct Offering of Common Stock
NEWTON, Mass., June 27, 2019 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics . . .
Posted on 6/28/19
Eutropics Awarded MassVentures Funding to Commercialize Novel Predictive Cancer Diagnostics Technology
Eutropics Pharmaceuticals Inc. (Eutropics) announced today that it has been awarded the highly competitive SBIR Targeted Technologies (START) program Stage III grant from MassVentures, a venture . . .
Posted on 6/28/19
Karuna Therapeutics Prices Upsized Initial Public Offering
BOSTON--(BUSINESS WIRE)--Karuna Therapeutics, Inc. (Nasdaq: KRTX), a clinical-stage biopharmaceutical company primarily focused on developing novel therapies to address disabling neuropsychiatric conditions, today announced the pricing of . . .
Posted on 6/27/19
SpringWorks Therapeutics Announces Global Clinical Collaboration with GlaxoSmithKline
STAMFORD, Conn.--(BUSINESS WIRE)--SpringWorks Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, today announced that the . . .

